GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

GSK launched Zantac in 1981 and it was first approved for sale in the US in 1983 as a prescription medication. It went on to become the world's best-selling drug, with annual sales in excess of $1bn.

Launched in 1988, Zantac was one of the first ever drugs ... Judge Vivian Medinilla of the Delaware Superior Court said instead, the strength of each side should be decided by a jury.